Capnia, Inc.

Industry · 8 registered clinical trials.

Status	Trial	Phase	Started
Completed	Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia Trigeminal Neuralgia	Phase 2	2015-09-01
Terminated	The Effect of Nasal Carbon Dioxide in the Treatment of Moderate to Severe Migraine Migraine	Phase 2	2012-01-01
Completed	The Effect of Nasal Carbon Dioxide (CO2) Used As-Needed in the Symptomatic Treatment of Seasonal Allergic Rhin Seasonal Allergic Rhinitis	Phase 2	2009-07-01
Completed	The Effect of Nasal Carbon Dioxide (CO2) in the Symptomatic Treatment of Seasonal Allergic Rhinitis Seasonal Allergic Rhinitis	Phase 2	2009-07-01
Completed	The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines Migraine	Phase 2	2008-08-01
Completed	The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Seasonal Allergic Rhinitis Seasonal Allergic Rhinitis	Phase 2	2008-07-01
Completed	The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic Rhinitis Perennial Allergic Rhinitis	Phase 2	2008-02-01
Completed	Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain Temporomandibular Disorders, Pain, Headaches	Phase 2	2007-02-01